Παρασκευή 30 Ιουνίου 2017

Switch to subsequent line of treatment in children and adolescents with chronic myeloid leukemia (CML) treated with imatinib : experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents (I-CML-Ped study)



http://ift.tt/2t7Jrq1

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου